NFA
GSK icon

Nationwide Fund Advisors’s GSK GSK Stock Holding History

Nationwide Fund Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-157,854
Closed -$8.01M – 871
2017
Q3 		$8.01M Sell
157,854
-41,628
-21% -$2.11M 0.03% 785
2017
Q2 		$10.8M Sell
199,482
-69,612
-26% -$3.71M 0.04% 609
2017
Q1 		$14.2M Sell
269,094
-576
-0.2% -$29.2K 0.06% 483
2016
Q4 		$13M Sell
269,670
-15,956
-6% -$788K 0.05% 489
2016
Q3 		$15.4M Buy
+285,626
New +$15.7M 0.06% 413
2016
Q1 		– Sell
-16,690
Closed -$831K – 3257
2015
Q4 		$842K Sell
16,690
-18,636
-53% -$950K ﹤0.01% 1811
2015
Q3 		$1.7M Sell
35,326
-3,558
-9% -$185K 0.01% 1456
2015
Q2 		$2.02M Sell
38,884
-1,821
-4% -$103K 0.01% 1420
2015
Q1 		$2.35M Sell
40,705
-29,330
-42% -$1.68M 0.01% 1374
2014
Q4 		$3.74M Buy
70,035
+52,357
+296% +$2.93M 0.02% 1088
2014
Q3 		$1.02M Sell
17,678
-778
-4% -$47.7K ﹤0.01% 1825
2014
Q2 		$1.23M Sell
18,456
-16,212
-47% -$1.1M 0.01% 1746
2014
Q1 		$2.31M Sell
34,668
-1,297
-4% -$87.7K 0.01% 1269
2013
Q4 		$2.4M Buy
35,965
+494
+1% +$32K 0.01% 1363
2013
Q3 		$2.22M Buy
35,471
+411
+1% +$26.5K 0.01% 1360
2013
Q2 		$2.19M Buy
+35,060
New +$2.23M 0.01% 1241

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Nationwide Fund Advisors's GSK Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of GSK (GSK) in Q4 2017, closing a stake of 157,854 shares — an estimated $8.01M sold.

Nationwide Fund Advisors first reported a position in GSK in Q2 2013 and held it in 16 quarters. The position peaked at $15.4M in Q3 2016. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining GSK position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 157,854 GSK shares in Q4 2017, an estimated $8.01M.
  • Nationwide Fund Advisors first reported a position in GSK in Q2 2013 and held it in 16 quarters.
  • Nationwide Fund Advisors's GSK position peaked at $15.4M in Q3 2016.
  • 763 funds tracked by Wall St. Rank held GSK as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.